Green Thumb Industries (GTBIF) Non-Current Deferred Tax Liability (2019 - 2026)
Green Thumb Industries (GTBIF) reported Non-Current Deferred Tax Liability of $220.6 million for Q1 2026, up 180.58% on a YoY basis from $78.6 million in Q1 2025, and little changed quarter-over-quarter from $220.6 million in Q4 2025.
Green Thumb Industries (GTBIF) Non-Current Deferred Tax Liability (2019 - 2026) Analysis & Trends
Green Thumb Industries has reported Non-Current Deferred Tax Liability for 8 years, with the latest figure at $220.6 million in Q1 2026.
- For the quarter ending Q1 2026, Non-Current Deferred Tax Liability rose 180.58% year-over-year to $220.6 million; the trailing twelve-month figure through Mar 2026 stood at $220.6 million (up 180.58% YoY), and the FY2025 full-year result was $220.6 million, up 32340.44% from the prior year.
- Non-Current Deferred Tax Liability for Q1 2026 stood at $220.6 million, roughly flat from $220.6 million in the prior quarter.
- The five-year high for Non-Current Deferred Tax Liability was $220.6 million in Q4 2025, with the low at $680000.0 in Q4 2024.
- Historically, Non-Current Deferred Tax Liability has averaged $86.0 million across 5 years, with a median of $72.5 million in 2023.
- Annual changes were most pronounced in 2024 — Non-Current Deferred Tax Liability slumped 99.06% — and 2025, when it jumped 32340.44%.
- Green Thumb Industries' Non-Current Deferred Tax Liability stood at $62.6 million in 2022, then grew by 15.92% to $72.5 million in 2023, then tumbled by 99.06% to $680000.0 in 2024, then jumped by 32340.44% to $220.6 million in 2025, then changed by 0.0% to $220.6 million in 2026.
- The last three Non-Current Deferred Tax Liability figures came in at $220.6 million (Q1 2026), $220.6 million (Q4 2025), and $78.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | Green Thumb Industries | - | - | 143.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 220.60 Mn |
| Mar 31, 2026 | 220.60 Mn |
| Dec 31, 2025 | 220.60 Mn |
| Dec 31, 2025 | 220.60 Mn |
| Sep 30, 2025 | 78.62 Mn |
| Sep 30, 2025 | 78.62 Mn |
| Jun 30, 2025 | 78.62 Mn |
| Jun 30, 2025 | 78.62 Mn |
| Mar 31, 2025 | 78.62 Mn |
| Mar 31, 2025 | 78.62 Mn |
| Dec 31, 2024 | 680,000.00 |
| Dec 31, 2024 | 680,000.00 |
| Sep 30, 2024 | 72.51 Mn |
| Sep 30, 2024 | 72.51 Mn |
| Jun 30, 2024 | 72.51 Mn |
| Jun 30, 2024 | 72.51 Mn |
| Mar 31, 2024 | 72.51 Mn |
| Mar 31, 2024 | 72.51 Mn |
| Dec 31, 2023 | 72.51 Mn |
| Dec 31, 2023 | 72.51 Mn |